Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2023 / Honorees / Tara Moore

Tara Moore

  • Profile

About Tara Moore

Chief of Research and Innovation, Avellino USA; Professor of Personalised Medicine at Ulster University, Northern Ireland, UK

 

Why did you decide to pursue ophthalmology/your subspecialty?

I met Professor Tony Adamis at ARVO in Fort Lauderdale when I was 22 years old, he invited me to work in his laboratory in Boston in MEEI and I have never looked back and remained in ophthalmology research since then.

What’s been the biggest breakthrough in ophthalmology/your specific field over the last 10 years? 

CRISPR, a genetic tool taken from bacteria, has empowered scientists in a way we never envisaged would be possible, enabling them to manipulate genes with profound accuracy and ease and potentially eliminating disease in an undreamt of way. The future of gene therapy for eye diseases will be a fascinating story to follow – I really hope my research team can be part of that story.

Do you have any personal missions for the next 10 years?

Over the coming years my personal mission and the mission of Avellino USA is to see a treatment for corneal dystrophy reach patients and the many families who currently have no available treatment to stop the disease taking their vision and the vision of their children.

Who would you invite to your dream dinner party?

My late father, who passed away over 25 years ago – before I had chosen a career or had a family, my mum, and my seven children. I can only imagine my dad’s reaction to an evening with us all!

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: